Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Analytical validation of GenoPharm a clinical genotyping open array panel of 46 pharmacogenes inclusive of variants unique to people of African ancestry. | PLoS One | 2023 | 37788265 | PubTator, text mining | PubMed |
| Implementing pharmacogenetic testing in fluoropyrimidine-treated cancer patients: DPYD genotyping to guide chemotherapy dosing in Greece. | Front Pharmacol | 2023 | 37781702 | PubTator, text mining | PubMed |
| Cancer awareness, diagnosis and treatment needs in Mizoram, India: evidence from 18 years trends (2003-2020). | Lancet Reg Health Southeast Asia | 2023 | 37780980 | PubTator, text mining | PubMed |
| The Incidence of Hematological Toxicities in Colorectal Cancer Patients Treated With Fluoropyrimidine-Based Regimens at Princess Noorah Oncology Center. | Cureus | 2023 | 37772227 | PubTator, text mining | PubMed |
| Whole-exome sequencing of calcitonin-producing pancreatic neuroendocrine neoplasms indicates a unique molecular signature. | Front Oncol | 2023 | 37771441 | PubTator, text mining | PubMed |
| Predictive value of DNA methylation in the efficacy of chemotherapy for gastric cancer. | Front Oncol | 2023 | 37771430 | PubTator, text mining | PubMed |
| A Novel Gliotransmitter, L-β-Aminoisobutyric Acid, Contributes to Pathophysiology of Clinical Efficacies and Adverse Reactions of Clozapine. | Biomolecules | 2023 | 37759688 | PubTator, text mining | PubMed |
| Genetic Variants in the Mitochondrial Thymidylate Biosynthesis Pathway Increase Colorectal Cancer Risk. | Curr Oncol | 2023 | 37754498 | PubTator, text mining | PubMed |
| Using oral tegafur/uracil (UFT) plus leucovorin as adjuvant chemotherapy in stage II colorectal cancer: a propensity score matching study from Taiwan. | BMC Cancer | 2023 | 37749535 | PubTator, text mining | PubMed |
| Cardiotoxicity of anti-cancer drugs: cellular mechanisms and clinical implications. | Front Cardiovasc Med | 2023 | 37745115 | PubTator, text mining | PubMed |
| Implementation of pharmacogenetic testing in oncology: DPYD-guided dosing to prevent fluoropyrimidine toxicity in British Columbia. | Front Pharmacol | 2023 | 37745065 | PubTator, text mining | PubMed |
| Musculoskeletal manifestations associated with transthyretin-mediated (ATTR) amyloidosis: a systematic review. | BMC Musculoskelet Disord | 2023 | 37740174 | PubTator, text mining | PubMed |
| Proteome-wide mendelian randomization study implicates therapeutic targets in common cancers. | J Transl Med | 2023 | 37735436 | PubTator, text mining | PubMed |
| Unraveling dynamically encoded latent transcriptomic patterns in pancreatic cancer cells by topic modeling. | Cell Genom | 2023 | 37719139 | PubTator, text mining | PubMed |
| Stroke-like presentation of acute toxic leukoencephalopathy due to capecitabine treatment with extensive intramyelinic edema. | Chronic Dis Transl Med | 2023 | 37711866 | PubTator, text mining | PubMed |
| Induction therapy with ipilimumab and nivolumab followed by consolidative chemoradiation as organ-sparing treatment in urothelial bladder cancer: study protocol of the INDIBLADE trial. | Front Oncol | 2023 | 37711193 | PubTator, text mining | PubMed |
| Whole Exome Analysis to Select Targeted Therapies for Patients with Metastatic Breast Cancer - A Feasibility Study. | Geburtshilfe Frauenheilkd | 2023 | 37706056 | PubTator, text mining | PubMed |
| Exploring prognostic markers for patients with acute myeloid leukemia based on cuproptosis related genes. | Transl Cancer Res | 2023 | 37701119 | PubTator, text mining | PubMed |
| Predicting Severe Haematological Toxicity in Gastrointestinal Cancer Patients Undergoing 5-FU-Based Chemotherapy: A Bayesian Network Approach. | Cancers (Basel) | 2023 | 37686482 | PubTator, text mining | PubMed |
| Population Pharmacogenomics in Croatia: Evaluating the PGx Allele Frequency and the Impact of Treatment Efficiency. | Int J Mol Sci | 2023 | 37686303 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=21